Abstract:Background Aging-related inflammation is associated with chronic diseases and mortality. This study aimed to: 1) develop composite inflammaging metrics (CIMs) in UK biobank (UKB), and validate them in UKB and National Health and Nutrition Examination Survey (NHANES); 2) estimate mortality and CVD risk predictions of CIMs; 3) compare CIMs with single inflammatory blood biomarkers and conventional inflammatory indexes; 4) examine associations between lifestyles and CIMs. Methods We utilized algorithms including multiple linear regression, principal component analysis (PCA), allostatic load (AL), and Klemera and Doubal method (KDM), to develop four CIMs from five inflammatory blood biomarkers, using data of 438,321 adults (40-70 years) from UK Biobank (UKB). We validated these CIMs in UKB and 10,667 adults (20-84 years) from NHANES IV. We performed a parametric proportional hazard model based on Gompertz distribution to estimate CVD and mortality risk predictions of CIMs. Areas under receiver operating characteristic curves (AUCs) were calculated to compare the predictive abilities of CIMs. Multiple linear regression models were used to access associations between lifestyles and CIMs. Results With adjustment for age and sex, four CIMs were significantly associated with higher risks of all-cause mortality and incident CVD in UKB, among which CIMKDM outperformed the others (all-cause mortality: hazard ratio [HR] = 1.48, 95% confidence interval [CI] = 1.46, 1.50; incident CVD: HR = 1.34, 95% CI = 1.33, 1.36). CIMKDM had the best discriminative ability for predicting 10-year survival and incident CVD in UKB (all-cause mortality: AUC = 0.728; incident CVD: AUC = 0.712). CIMs were responsive to lifestyle variables. For example, in UKB, compared to never smokers, current smokers had a significant increment in CIMKDM (coefficient = 0.30 SD, P < 0.001). Similar results were well validated in NHANES IV. Conclusions We developed and validated four novel CIMs that were predictive of mortality and CVD risk. CIMKDM outperformed the others and had the potential to be used in aging related preventive and intervention programs. Intervention programs targeting lifestyles could slow inflammaging and further reduce disease burden. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LQ21H260003), the National Natural Science Foundation of China (82171584), the 2020 Milstein Medical Asian American Partnership Foundation Irma and Paul Milstein Program for Senior Health project award (ZL), fundings from Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province (2020E10004), and Zhejiang University Global Partnership Fund (188170-11103). The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: UKB data was approved by the North West Multi-centre Research Ethics Committee (ref. 11/NW/0382). All participants provided written informed consent. NHANES data were openly available to the public before the initiation of the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes NHANES data produced are available online at (https://www.cdc.gov/nchs/nhanes/index.htm). UKB data has been conducted using the UKB resource under application number 61856.

Biological Features of the Outcome-Based Intrinsic Capacity Composite Scores From a Population-Based Cohort Study: Pas de Deux of Biological and Functional Aging

Social Determinants of Intrinsic Capacity: A National Cohort Study.

Abstract 4137594: Intrinsic Capacity Trajectories and Cardiovascular Disease among Chinese Older Adults: A Population-Based Longitudinal Study

Development and Validation of an Intrinsic Capacity Score in the UK Biobank Study

Aging Metrics Incorporating Cognitive and Physical Function Capture Mortality Risk: Results from Three Prospective Cohort Studies

Development and validation of composite inflammaging metrics: Findings from two prospective cohort studies

Development and Validation of Two Composite Aging Measures Using Clinical Biomarkers in the Chinese Population

The development of intrinsic capacity measures for longitudinal research: The Longitudinal Aging Study Amsterdam

Construction of a comprehensive evaluation system for assessing intrinsic capacity in community older adults

A simple scoring algorithm based on intrinsic capacity for functional ability in community-dwelling older adults in Taiwan

Enhancing Intrinsic Capacity and Related Biomarkers in Community-Dwelling Multimorbid Older Adults Through Integrated Multidomain Interventions: Ancillary Findings From the Taiwan Integrated Geriatric (TIGER) Trial

Association between aging-related biomarkers and longitudinal trajectories of intrinsic capacity in older adults

Association of intrinsic capacity with functional ability, sarcopenia and systemic inflammation in pre-frail older adults

Intrinsic Capacity: Validation of a New WHO Concept for Healthy Aging in a Longitudinal Chinese Study.

Association of Intrinsic Capacity with Frailty, Physical Fitness and Adverse Health Outcomes in Community-Dwelling Older Adults

Roles of Baseline Intrinsic Capacity and its Subdomains on the Overall Efficacy of Multidomain Intervention in Promoting Healthy Aging among Community-Dwelling Older Adults: Analysis from a Nationwide Cluster-Randomized Controlled Trial

Association of intrinsic capacity with functional decline and mortality in older adults: a systematic review and meta-analysis of longitudinal studies

Predictive Value of Intrinsic Capacity on Adverse Outcomes among Community-Dwelling Older Adults.

Adverse outcomes of intrinsic capacity in older adults: A scoping review

Association of Intrinsic Capacity with Incident Type 2 Diabetes Mellitus in Older Chinese: Guangzhou Biobank Cohort Study

A Novel Blood-Based Epigenetic Clock for Intrinsic Capacity Predicts Mortality and is Associated with Clinical, Immunological and Lifestyle Factors